Response and resistance in a non-small-cell lung cancer patient with an epidermal growth factor receptor mutation and leptomeningeal metastases treated with high-dose gefitinib

Cited by (262)

Items 201–262 of 262

1. Efficacy of a lumbo-peritoneal shunt for meningeal carcinomatosis refractory to gefitinib treatment.
   Toshio Kubo, Nagio Takigawa, Katsuyuki Kiura, Ayumi Nishida, Nobuaki Ochi, Hiromi Kashihara, Shigeki Umemura, Akiko Hisamoto, Mitsune Tanimoto · 2009 · PubMed
2. Complete remission through icotinib treatment in Non-small cell lung cancer epidermal growth factor receptor mutation patient with brain metastasis: A case report
   Tao Wang, Ruimin Wang, Zhouhuan Dong, Naichao Liang, Ping Chang · 2016 · Open Medicine
3. Erlotinib plus concurrent whole-brain radiation therapy for non-small cell lung cancers patients with multiple brain metastases
   Danny Ulahannan, Siow Ming Lee · 2016 · Translational Lung Cancer Research
4. Response of Intracranial Metastases to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: It May All Depend on EGFR Mutations
   Daniel Botelho Costa, Susumu S. Kobayashi · 2008 · Journal of Clinical Oncology
5. [Advances in treatment of brain metastases from primary non-small cell lung cancer].
   Gen Lin, Haipeng Xu, Cheng Huang · 2014 · Europe PMC (PubMed Central)
6. A phase I dose-escalation study of pulsatile afatinib in patients with recurrent or progressive brain cancer
   Tiffany Juarez, Jaya Mini Gill, Annie Heng, Jose Carrillo, Naveed A. Wagle, Natsuko Nomura, Minhdan Nguyen, Judy Truong, Lucia Dobrawa, Walavan Sivakumar et al. · 2024 · Neuro-Oncology Advances
7. [Vandetanib treatment in refractory advanced lung adenocarcinoma patients: five cases and review of literature].
   Lili Guo, Junfang Tang, Qiyi Meng, Yunzhong Zhu, Li‐Yan Xu, Heling Shi, Zhe Liu · 2012 · Europe PMC (PubMed Central)
8. Two Cases of Lung Cancer with Carcinomatous Meningitis in Which Erlotinib Was Effective After Gefitinib Therapy
   Takeshi Masuda, Kazuhide Fukuhara, Takashi Yoshida, Kikuo Nakano, Kenichi Omori, Kiyomi Taniyama · 2009 · Haigan
9. Cerebrospinal Fluid Spread of Anaplastic Glioma
   Ozden Narin, Jan Drappatz, Lisa M. Doherty, Patrick Yung Wen, Santosh Kesari · 2007 · Journal of Clinical Oncology
10. Erlotinib Responds to Brain Metastasis of Lung Adenocarcinoma where Gefitinib Failed : A Case Report
    Chika Sato, Manabu Yokota, Kimikazu Iwamoto, Toru Nakanishi, Maiko Tanaka · 2012 · Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
11. Long‐lasting response to third‐line crizotinib treatment in a patient with non‐small cell lung cancer with brain metastases and poor performance status
    Delan Li, Xin-ru Chen, Shu-xiang Ma, Li‐kun Chen · 2016 · Thoracic Cancer
12. Erlotinib May be More Effective for Central Nervous Metastasis of Lung Adenocarcinoma Than Gefitinib Because of the Difference in the Clinical Regimes
    Imahashi · 2011 · Journal of Medical Cases
13. Neurologic Complications of Lung Cancer
    Suriya A. Jeyapalan, Anand Mahadevan · 2008 · Humana Press eBooks
14. Molecular Pathology of Lung Cancer
    Alejandro H. Corvalán, Ignacio Ivan Wistuba · 2010 · Humana Press eBooks
15. Leptomeningeal Disease and the Role of Intrathecal Therapy
    Fadi S. Saadeh, Adrienne Ann Boire · 2020 · Springer eBooks
16. Efficacy of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small cell lung cancer.
    Tomonobu Koizumi, Shigeru Sasaki, Akiyuki Sakamoto, Takashi Kobayashi · 2013 · PubMed
17. Erlotinib May be More Effective for Central Nervous Metastasis of Lung Adenocarcinoma Than Gefitinib Because of the Difference in the Clinical Regimes
    Yumiko Imahashi, Naoko Shinmura, Daijiro Nabeya, Kyoko Inui, Takashi Ueji, Mio Hayakawa, Kenichiro Otani, Kyoko Yagyu, Takao Kamimori, Hiroshi Fujiwara · 2011 · Journal of Medical Cases
18. Three Cases of Leptomeningeal Carcinomatosis from Lung Adenocarcinoma Responding to EGFR TKIs
    Yoko Kida, Akito Hata, Reiko Kaji, Keisuke Tomii, Nobuyuki Katakami, Kyosuke Ishihara · 2009 · Haigan
19. Molecular characterization of cerebrospinal fluid tumor cells associated with leptomeningeal carcinomatosis
    2014 · Cancer Cell & Microenvironment
20. Les cancers bronchiques non à petites cellules EGFR-mutés
    Simon Baldacci, Alexis Benjamin Cortot · 2016 · Revue des Maladies Respiratoires Actualités
21. [Clinical Experience with First-generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer Patients with Brain Metastasis].
    Huixing Dong, Shaohua Cui, Feng Pan, Lili Dong, Yanjie Niu, Yizhuo Zhao, Aiqin Gu, Xiaoyan Jin, Liyan Jiang · 2017 · Europe PMC (PubMed Central)
22. TARGET ONCOGENIC RECEPTORS IN TUMOURS, FROM ITS INITIAL CLINICAL BREAKTHROUGHS TO CURRENT CLINICAL STANDARD THERAPY
    George Zhu · 2024 · Universal Journal of Pharmaceutical Research
23. Neoplastic Meningitis
    Sophie Taillibert, Émilie Le Rhun, Marc Charles Chamberlain · 2016 · Elsevier eBooks
24. Growth Factor Signaling Pathways and Targeted Therapy
    Kenneth D. Swanson, Alain Charest, Ian F. Pollack, Eric T. Wong · 2018 · Elsevier eBooks
25. Clinical outcome of Brazilian patients with non-small cell lung cancer in early stage harboring rare mutations in epidermal growth factor receptor
    Juliana Rodrigues Machado Rúgolo, Camila Machado Baldavira, Tabatha Gutierrez Prieto, Eloísa Helena Ribeiro Olivieri, Alexandre Todorovic Fabro, Cláudia Aparecida Rainho, Erick C. Castelli, Paulo Eduardo Martins Ribolla, Alexandre Muxfeldt Ab’Saber, Teresa Yae Takagaki et al. · 2022 · Brazilian Journal of Medical and Biological Research
26. Niraparib as a therapeutic agent for the treatment of ovarian cancer meningeal dissemination with BRCA1 mutation
    Takashi Nei, Satoshi Tamauchi, Yoshiki Ikeda, Nobuhisa Yoshikawa, Kaoru Niimi, Hiroaki Kajiyama · 2023 · Journal of obstetrics and gynaecology research
27. Brain Metastasis in Patients with Non-Small Cell Lung Cancer: Response to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
    Anne-Marie Ruppert, Perrine Créquit, A. Lavolé, Marie Wislez, Jacques L. Cadranel, Valérie Gounant · 2015 · Elsevier eBooks
28. [Research Progress of Mechanisms on Intracranial Metastasis of Non-small Cell Lung Cancer after Clinical Benefit from EGFR-TKI].
    Juan Jiang, Chengping Hu · 2015 · Europe PMC (PubMed Central)
29. A Case of Miliary Brain Metastasis of Lung Cancer Mimicking Neurocysticercosis
    Ho-Jun Lee, In‐Jae Oh, Sang-Woo Park, Hee‐Jung Ban, Young‐Chul Kim, Soo-Ok Kim · 2012 · Tuberculosis & respiratory diseases
30. Response to CCR-07-0070
    William J. Pao, Yixuan Gong, Marissa N. Balak · 2007 · Clinical Cancer Research
31. Management of Leptomeningeal Metastasis in Patients with Lung Cancer
    Shigeki Umemura · 2013 · Lung Cancer Management
32. Clinical significance of gefitinib antitumor activity in patients with lung adenocarcinoma
    Zhun Wang, Qianbo Han, Jialei Gu, XIN-MIN YU, Xiaojiang Sun, Qingren Lin, Jun Qun Fang, YUE-ZHEN WANG, YA-PING XU, Weimin Mao · 2014 · Oncology Letters
33. Possibilities of Targeted Therapies for Brain Metastasis
    Frank Winkler · 2012 · Cancer metastasis
34. Traitement des progressions tumorales dans le cancer du poumon muté EGFR : à propos d'une cohorte de patients métastatiques suivis à l'Institut Bergonié
    Charlotte Domblides · 2015 · HAL
35. The Continuation of Erlotinib Treatment in Non-Small Cell Lung Cancer Patients Whose Brain Lesion Is the Only Site of Progression: Prospective Pilot Study
    Kwai Han Yoo, Seung Tae Kim, Ki Sun Jung, Ji Yun Lee, Sung Hee Lim, Min‐Young Lee, Hae Soo Kim, Hee Jin Kwon, In Young Kim, Jong‐Mu Sun et al. · 2015 · Hanyang Medical Reviews
36. Inhibitory kinazy tyrozynowej EGFR w leczeniu przerzutów do mózgu w przebiegu niedrobnokomórko
    Renata Duchnowska · 2009
37. Efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors for patient with leptomeningeal metastasis of epidermal growth factor receptor mutant non-small cell lung cancer
    Jong Sik Lee, Kyung Ann Lee, Kang Hoon Lee, Sun Young Moon, In Ae Kim, Sung Jin Jeon, Jae Ki Min, Hee Joung Kim, Kye Young Lee · 2016 · Journal of Yeungnam Medical Science
38. First-line therapy of advanced non-small cell lung cancer with activatingEGFRmutations
    Caicun Zhou · 2012 · Informa Healthcare eBooks
39. [Research Progress of EGFR-TKI Therapy for Patients with Central Nervous System Metastases from Non-small Cell Lung Cancer].
    Yinghua Jin, Tao Xin · 2016 · Europe PMC (PubMed Central)
40. EGFR tyrosine kinase inhibitors in the treatment of brain metastases in non-small cell lung cancer
    Renata Duchnowska · 2009 · Oncology in Clinical Practice
41. PP01. TARGETING MYC/MYCN BY INHIBITION OF CHECKPOINT KINASE 1 (CHK1) SENSITIZES PAEDIATRIC GLIOBLASTOMA (PGBM) CELLS TO TEMOZOLOMIDE
    Meera Nandhabalan · 2017 · Neuro-Oncology
42. Intracranial Disease in Patients with Non-Small Cell Lung Cancer
    Mazhar A. Ajaz, Fiona McDonald, Jaishree Bhosle, Paola Bordi, Mary E.R. O'Brien · 2014 · Elsevier eBooks
43. Leptomeningeal Metastasis as Complication of Systemic Cancers
    Sophie Taillibert, Émilie Le Rhun, Marc Charles Chamberlain · 2017 · Springer eBooks
44. Cerebrospinal Fluid Concentration of Crizotinib and Its Activity Against Brain Metastasis in an Elderly Patient
    Yohsuke Sugiyama, Hitoshi Nakaji, Yuichi Sakamori, Satoshi Terashita, Tetsuhiro Shiota · 2017 · Haigan
45. Brain Metastases and Neoplastic Meningitis
    Orit Kaidar‐Person, Michael J. Cools, Timothy M. Zagar · 2020 · Elsevier eBooks
46. The evolution of views on the possibilities of drug therapy in overcoming acquired resistance not associated with Т790М mutation to anti-EGFR drugs in non-small cell lung cancer
    Е. В. Карабина, Ludmila N. Lubchenko, A. N. Garunov · 2018 · Journal of Modern Oncology
47. A Sensitive PCR-Based Method for Somatic Mutations Enrichment and Screening
    Yaming Xiong, Hailin Tang · 2021 · Cancer Management and Research
48. Les cancers bronchiques non à petites cellules EGFR-mutés
    Simon Baldacci, R. Gervais, Alexis Benjamin Cortot · 2017 · Revue des Maladies Respiratoires Actualités
49. Benzene fused pyrimidine-based derivatives and their biological properties
    Jeremy M. Kelm, Hariprasad Aruri, Prasanth R. Nyalapatla, Navnath S. Gavande · 2022 · Elsevier eBooks
50. Treatment of Isolated Intracranial Progression of Lung Cancer During Treatment with Systemic Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR-TKIs)
    Amanda Tufman, Kathrin Schrödl, Heike Scheithauer, Thomas Duell, Eva Coppenrath, Rudolf Maria Hube · 2015 · EMJ Respiratory
51. Data from Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Lung Cancer: Distinct Natural History of Patients with Tumors Harboring the T790M Mutation
    Geoffrey R. Oxnard, Maria E. Arcila, Camelia S. Sima, Gregory J. Riely, Juliann Chmielecki, Mark G. Kris, William J. Pao, Marc Ladanyi, Vincent A. Miller · 2023
52. Data from Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Lung Cancer: Distinct Natural History of Patients with Tumors Harboring the T790M Mutation
    Geoffrey R. Oxnard, Maria E. Arcila, Camelia S. Sima, Gregory J. Riely, Juliann Chmielecki, Mark G. Kris, William J. Pao, Marc Ladanyi, Vincent A. Miller · 2023
53. Data from Double EGFR mutants containing rare EGFR mutant types show reduced in vitro response to gefitinib compared with common activating missense mutations
    Issan Yee San Tam, Elaine Lai‐Han Leung, Vicky Pui‐Chi Tin, Daniel Tsin-Tien Chua, Alan Dart‐Loon Sihoe, Lik‐Cheung Cheng, Lap-Ping Chung, Maria Pik Wong · 2023
54. Data from Double EGFR mutants containing rare EGFR mutant types show reduced in vitro response to gefitinib compared with common activating missense mutations
    Issan Yee San Tam, Elaine Lai‐Han Leung, Vicky Pui‐Chi Tin, Daniel Tsin-Tien Chua, Alan Dart‐Loon Sihoe, Lik‐Cheung Cheng, Lap-Ping Chung, Maria Pik Wong · 2023
55. Data from Epidermal Growth Factor Receptor Abnormalities in the Pathogenesis and Progression of Lung Adenocarcinomas
    Ximing Tang, Marileila Varella-Garcia, Ana C. Xavier, Erminia Massarelli, Natalie C. Ozburn, César A. Moran, Ignacio Ivan Wistuba · 2023
56. Perfil molecular das vias de sinalização dos carcinomas de pulmão de células não pequenas por Sequenciamento de Nova Geração (NGS) com ênfase à Transição Epitélio Mesenquimal (EMT)
    Juliana Rodrigues Machado Rúgolo · 2023 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
57. Complete response in a lung adenocarcinoma with pleural metastases initially treated with gefitinib and switched to osimertinib after cerebral oligo-progression with unknown T790M mutation: a case report and review of literature
    Mariem Hachlaf, Sihame Lkhoyaali, Wydad Nadir, Hajar Lemsyeh, Brahim el Ghissassi, Hind M’rabti, Saber Boutayeb, Hassan H Errihani · 2024 · Journal of Medical Case Reports
58. Tyrosine kinase inhibitors in the treatment of leptomeningeal carcinomatosis
    Hanyu Ni, Zilan Wang, Yanbing Tang, Jiaye Lu, Zixiang Zhu, Youjia Qiu, Zhouqing Chen, Zhong Wang · 2024 · Cell Biology International
59. Growth factor signaling pathways and targeted therapy
    Sonikpreet Aulakh · 2026 · Elsevier eBooks
60. Rôle des calpaïnes extracellulaires dans la progression des adénocarcinomes lépidiques
    Anne-Marie Ruppert · 2015
61. BindingDB Entry 50046648: Discovery and Evaluation of Clinical Candidate AZD3759, a Potent, Oral Active, Central Nervous System-Penetrant, Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor.
    BindingDB · 2016 · UC San Diego
62. BindingDB Entry 50018884: Small Molecule Kinase Inhibitors for the Treatment of Brain Cancer.
    BindingDB · 2024 · UC San Diego